Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel · Delayed Price · Currency is ILS · Price in ILA 24.90
-0.90 (-3.49%)
Aug 3, 2026, 5:24 PM IDT
TLV:CBI Market Cap
TLV:CBI has a market cap or net worth of 39.37 million as of August 3, 2026. Its market cap has decreased by -23.94% in one year.
Market Cap
39.37M
Enterprise Value
58.12M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
24.90
ChartMarket Cap Chart
Since July 23, 2007, TLV:CBI's market cap has decreased from 797.05M to 39.37M, a decrease of -95.06%. That is a compound annual growth rate of -14.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 39.37M | -17.43% |
| Dec 31, 2025 | 47.68M | -12.89% |
| Dec 31, 2024 | 54.74M | -12.09% |
| Dec 31, 2023 | 62.27M | -36.78% |
| Dec 29, 2022 | 98.50M | -46.87% |
| Dec 30, 2021 | 185.39M | -41.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geffen Residence & Renewal | 322.94M |
| Bonus BioGroup | 309.56M |
| Matricelf | 72.59M |
| BioLineRx | 41.94M |
| BioLight Life Sciences | 31.56M |
| Can-Fite BioPharma | 22.11M |
| XTL Biopharmaceuticals | 19.66M |
| Purple Biotech | 18.65M |